Dr. Fryzek has 30 years of experience in the pharmaceutical industry and private consulting firms. He has conducted epidemiologic studies of cancer, connective tissue diseases, neurological diseases, infectious diseases, chronic renal failure, and medical devices. Dr. Fryzek has led numerous studies based on Real-World Evidence, including descriptive incidence studies, disease treatment pattern studies, and co-morbidity assessments in support of drug development and safety. Among his many occupational studies, he has evaluated disease risk in aerospace workers, chemical manufacturers, welders, and other occupational groups.
Dr. Fryzek’s environmental studies have involved examining the risk associated with DDT and other pesticides for pancreatic cancer patients, as well as the risk of environmental chromium associated with cancer. In support of drug development and drug safety, he has performed studies elucidating the natural history of various diseases, including descriptive incidence studies, “real-world” disease treatment pattern studies, and co-morbidity assessments. Dr. Fryzek has over 150 peer-reviewed manuscripts, book chapters, and scientific meeting abstracts. He has published in the New England Journal of Medicine, the Annals of Internal Medicine, the Journal of the National Cancer Institute, and the Journal of Occupational and Environment Medicine, among others, and is a scientific reviewer for a number of journals, including the American Journal of Epidemiology, Cancer Epidemiology, Biomarkers and Prevention, and the International Journal of Cancer. Dr. Fryzek is currently Adjunct Professor, Georgetown University Medical Center; Adjunct Professor, University of Pittsburgh School of Public Health; and Visiting Professor in the Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.